{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:56:11Z","timestamp":1792079771714,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD101534"],"award-info":[{"award-number":["R01HD101534"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21MH109761"],"award-info":[{"award-number":["R21MH109761"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL 1TR002541"],"award-info":[{"award-number":["UL 1TR002541"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.celrep.2022.111312","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T11:24:07Z","timestamp":1662463447000},"page":"111312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Molecular convergence between Down syndrome and fragile X syndrome identified using human pluripotent stem cell models"],"prefix":"10.1016","volume":"40","author":[{"given":"Sara G.","family":"Susco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulagna","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Mazzucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Beccard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Berryer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Messana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dane Z.","family":"Hazelbaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy E.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.111312_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2014.03.040","article-title":"A chromatin-dependent role of the fragile X mental retardation protein FMRP in the DNA damage response","volume":"157","author":"Alpatov","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111312_bib2","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1172\/JCI63141","article-title":"Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics","volume":"122","author":"Bagni","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111312_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.scr.2016.09.008","article-title":"Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9","volume":"17","author":"Bara","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.celrep.2022.111312_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ajmg.c.30097","article-title":"Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome","volume":"142C","author":"Capone","year":"2006","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib5","doi-asserted-by":"crossref","first-page":"108179","DOI":"10.1016\/j.celrep.2020.108179","article-title":"Replication stress induces global chromosome breakage in the fragile X genome","volume":"32","author":"Chakraborty","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111312_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.stem.2019.04.021","article-title":"Direct reprogramming of human neurons identifies MARCKSL1 as a pathogenic mediator of valproic acid-induced teratogenicity","volume":"25","author":"Chanda","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2022.111312_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.molcel.2014.03.023","article-title":"Fragile X mental retardation protein regulates translation by binding directly to the ribosome","volume":"54","author":"Chen","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2022.111312_bib8","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1038\/s41380-020-00912-2","article-title":"Genetic association of FMRP targets with psychiatric disorders","volume":"26","author":"Clifton","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.celrep.2022.111312_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12859-018-2139-9","article-title":"VIPER: visualization Pipeline for RNA-seq, a Snakemake workflow for efficient and complete RNA-seq analysis","volume":"19","author":"Cornwell","year":"2018","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.celrep.2022.111312_bib10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jmedgenet-2012-101251","article-title":"The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy","volume":"49","author":"Courcet","year":"2012","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1515\/hsz-2019-0221","article-title":"Aberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndrome","volume":"401","author":"D'Antoni","year":"2020","journal-title":"Biol. Chem."},{"key":"10.1016\/j.celrep.2022.111312_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.isci.2018.11.007","article-title":"FMRP interacts with C\/D box snoRNA in the nucleus and regulates ribosomal RNA methylation","volume":"9","author":"D'Souza","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2022.111312_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111312_bib14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.tig.2017.07.008","article-title":"Multifarious functions of the fragile X mental retardation protein","volume":"33","author":"Davis","year":"2017","journal-title":"Trends Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","article-title":"Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"15","author":"de la Torre","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2022.111312_bib16","first-page":"4235898","article-title":"Where environment meets cognition: a focus on two developmental intellectual disability disorders","volume":"2016","author":"De Toma","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.celrep.2022.111312_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature21062","article-title":"Prevalence and architecture of de novo mutations in developmental disorders","volume":"542","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111312_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s11689-020-09320-7","article-title":"Expressive language development in adolescents with Down syndrome and fragile X syndrome: change over time and the role of family-related factors","volume":"12","author":"Del Hoyo Soriano","year":"2020","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.celrep.2022.111312_bib19","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/hmg\/ddi404","article-title":"Gene expression variation and expression quantitative trait mapping of human chromosome 21 genes","volume":"14","author":"Deutsch","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.devcel.2008.04.003","article-title":"A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome","volume":"14","author":"Dictenberg","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.celrep.2022.111312_bib21","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1093\/nar\/gkn472","article-title":"The G-quartet containing FMRP binding site in FMR1 mRNA is a potent exonic splicing enhancer","volume":"36","author":"Didiot","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2022.111312_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2022.111312_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-160836","article-title":"Down syndrome, partial trisomy 21, and absence of alzheimer's disease: the role of APP","volume":"56","author":"Doran","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.celrep.2022.111312_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnbeh.2016.00104","article-title":"DYRK1A, a dosage-sensitive gene involved in neurodevelopmental disorders, is a target for drug development in Down syndrome","volume":"10","author":"Duchon","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.celrep.2022.111312_bib25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.celrep.2019.06.072","article-title":"FMRP modulates neural differentiation through m(6)a-dependent mRNA nuclear export","volume":"28","author":"Edens","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111312_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.euroneuro.2018.03.006","article-title":"Translating molecular advances in Down syndrome and Fragile X syndrome into therapies","volume":"28","author":"Faundez","year":"2018","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.celrep.2022.111312_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/TLD.0b013e3181a72016","article-title":"Language development in individuals with fragile X syndrome","volume":"29","author":"Finestack","year":"2009","journal-title":"Top. Lang. Disord."},{"key":"10.1016\/j.celrep.2022.111312_bib28","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/bioinformatics\/bts503","article-title":"Qualimap: evaluating next-generation sequencing alignment data","volume":"28","author":"Garc\u00eda-Alcalde","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2022.111312_bib29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ajhg.2008.03.018","article-title":"A defect in the TUSC3 gene is associated with autosomal recessive mental retardation","volume":"82","author":"Garshasbi","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib30","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.stemcr.2017.05.012","article-title":"Taming human genetic variability: transcriptomic meta-analysis guides the experimental design and interpretation of iPSC-based disease modeling","volume":"8","author":"Germain","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.celrep.2022.111312_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1126\/science.aas9963","article-title":"Fragile X mental retardation 1 gene enhances the translation of large autism-related proteins","volume":"361","author":"Greenblatt","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111312_bib32","doi-asserted-by":"crossref","first-page":"e78561","DOI":"10.1371\/journal.pone.0078561","article-title":"Alterations to dendritic spine morphology, but not dendrite patterning, of cortical projection neurons in Tc1 and Ts1Rhr mouse models of Down syndrome","volume":"8","author":"Haas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111312_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2377-10-90","article-title":"Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: a case control study","volume":"10","author":"Han","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.celrep.2022.111312_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tins.2011.11.001","article-title":"Trisomy 21 and early brain development","volume":"35","author":"Haydar","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.celrep.2022.111312_bib35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41598-020-57500-1","article-title":"A multiplexed gRNA piggyBac transposon system facilitates efficient induction of CRISPRi and CRISPRa in human pluripotent stem cells","volume":"10","author":"Hazelbaker","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2022.111312_bib36","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.stemcr.2017.09.006","article-title":"A scaled framework for CRISPR editing of human pluripotent stem cells to study psychiatric disease","volume":"9","author":"Hazelbaker","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.celrep.2022.111312_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/emmm.201302848","article-title":"Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21","volume":"6","author":"Hibaoui","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celrep.2022.111312_bib38","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1601-183X.2012.00768.x","article-title":"Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome","volume":"11","author":"Hoeffer","year":"2012","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.celrep.2022.111312_bib39","doi-asserted-by":"crossref","first-page":"9335","DOI":"10.1073\/pnas.1002762107","article-title":"Region-specific alterations in brain development in one- to three-year-old boys with fragile X syndrome","volume":"107","author":"Hoeft","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111312_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41380-018-0029-1","article-title":"New considerations for hiPSC-based models of neuropsychiatric disorders","volume":"24","author":"Hoffman","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.celrep.2022.111312_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature13908","article-title":"The contribution of de novo coding mutations to autism spectrum disorder","volume":"515","author":"Iossifov","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111312_bib42","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1093\/hmg\/ddy291","article-title":"Protein synthesis levels are increased in a subset of individuals with fragile X syndrome","volume":"27","author":"Jacquemont","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib43","doi-asserted-by":"crossref","first-page":"g5596","DOI":"10.1136\/bmj.g5596","article-title":"Managing the care of adults with Down's syndrome","volume":"349","author":"Jensen","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.celrep.2022.111312_bib44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ygeno.2013.12.001","article-title":"Neuronatin gene: imprinted and misfolded: studies in Lafora disease, diabetes and cancer may implicate NNAT-aggregates as a common downstream participant in neuronal loss","volume":"103","author":"Joseph","year":"2014","journal-title":"Genomics"},{"key":"10.1016\/j.celrep.2022.111312_bib45","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41593-021-00913-6","article-title":"A human forebrain organoid model of fragile X syndrome exhibits altered neurogenesis and highlights new treatment strategies","volume":"24","author":"Kang","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2022.111312_bib46","doi-asserted-by":"crossref","first-page":"660843","DOI":"10.3389\/fnagi.2021.660843","article-title":"Mitochondrial CHCHD2: disease-associated mutations, physiological functions, and current animal models","volume":"13","author":"Kee","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.celrep.2022.111312_bib47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/stem.2505","article-title":"Depletion of the fragile X mental retardation protein in embryonic stem cells alters the kinetics of neurogenesis","volume":"35","author":"Khalfallah","year":"2017","journal-title":"Stem Cell."},{"key":"10.1016\/j.celrep.2022.111312_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/MCB.01377-08","article-title":"Fragile X mental retardation protein FMRP binds mRNAs in the nucleus","volume":"29","author":"Kim","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.celrep.2022.111312_bib49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.aax4240","article-title":"Phospho-dependent phase separation of FMRP and CAPRIN1 recapitulates regulation of translation and deadenylation","volume":"365","author":"Kim","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111312_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/hmg\/ddl437","article-title":"The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease","volume":"16","author":"Kimura","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib51","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1038\/ncomms9836","article-title":"Abeta-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease","volume":"6","author":"Leshchyns'ka","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111312_bib52","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2022.111312_bib53","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with alzheimer's disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111312_bib54","doi-asserted-by":"crossref","first-page":"E11397","DOI":"10.1073\/pnas.1809588115","article-title":"Regulatory discrimination of mRNAs by FMRP controls mouse adult neural stem cell differentiation","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111312_bib55","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btv423","article-title":"CRISPR-ERA: a comprehensive design tool for CRISPR-mediated gene editing, repression and activation","volume":"31","author":"Liu","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2022.111312_bib56","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ygeno.2007.08.005","article-title":"Gene expression profiling in the adult Down syndrome brain","volume":"90","author":"Lockstone","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.celrep.2022.111312_bib57","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2022.111312_bib58","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/ddy447","article-title":"Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a","volume":"28","author":"Marechal","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib59","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/TLD.0b013e3181a71fe1","article-title":"Language characteristics of individuals with Down syndrome","volume":"29","author":"Martin","year":"2009","journal-title":"Top. Lang. Disord."},{"key":"10.1016\/j.celrep.2022.111312_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt Removes Adapter Sequences from High-Throughput Sequencing Reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet. journal"},{"key":"10.1016\/j.celrep.2022.111312_bib61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/dneu.22417","article-title":"Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models","volume":"77","author":"Mart\u00ednez-Cerde\u00f1o","year":"2017","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.celrep.2022.111312_bib62","first-page":"76","article-title":"Down syndrome and leukemia: insights into leukemogenesis and translational targets","volume":"4","author":"Mateos","year":"2015","journal-title":"Transl. Pediatr."},{"key":"10.1016\/j.celrep.2022.111312_bib63","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajhg.2020.02.013","article-title":"De novo frameshift variants in the neuronal splicing factor NOVA2 result in a common C-terminal extension and cause a severe form of neurodevelopmental disorder","volume":"106","author":"Mattioli","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib64","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/cne.22651","article-title":"PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca(2+)\/calmodulin-dependent kinase II-delta activation in mouse models of Down syndrome","volume":"519","author":"Mouton-Liger","year":"2011","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.celrep.2022.111312_bib65","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.celrep.2018.04.066","article-title":"Combining NGN2 programming with developmental patterning generates human excitatory neurons with NMDAR-mediated synaptic transmission","volume":"23","author":"Nehme","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111312_bib66","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1126\/science.1227764","article-title":"Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders","volume":"338","author":"O'Roak","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111312_bib67","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.stem.2015.07.017","article-title":"Human neuropsychiatric disease modeling using conditional deletion reveals synaptic transmission defects caused by heterozygous mutations in NRXN1","volume":"17","author":"Pak","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2022.111312_bib68","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1073\/pnas.1911895116","article-title":"Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome","volume":"116","author":"Panagaki","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111312_bib69","article-title":"Accurate, fast, and model-aware transcript expression quantification with salmon","author":"Patro","year":"2015","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2022.111312_bib70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejmg.2014.11.004","article-title":"21q21 deletion involving NCAM2: report of 3 cases with neurodevelopmental disorders","volume":"58","author":"Petit","year":"2015","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib71","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/519248","article-title":"Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance","volume":"81","author":"Prandini","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib72","doi-asserted-by":"crossref","first-page":"108991","DOI":"10.1016\/j.celrep.2021.108991","article-title":"Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis","volume":"35","author":"Raj","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111312_bib73","first-page":"923","article-title":"Brain ventriculomegaly in Down syndrome mice is caused by Pcp4 dose-dependent cilia dysfunction","volume":"26","author":"Raveau","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib74","doi-asserted-by":"crossref","first-page":"e1004432","DOI":"10.1371\/journal.pgen.1004432","article-title":"Genetic background drives transcriptional variation in human induced pluripotent stem cells","volume":"10","author":"Rouhani","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib75","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.neuron.2015.09.016","article-title":"Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci","volume":"87","author":"Sanders","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111312_bib76","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cell.2019.12.036","article-title":"Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism","volume":"180","author":"Satterstrom","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111312_bib77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111312_bib78","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1016\/j.celrep.2020.02.076","article-title":"FMRP control of ribosome translocation promotes chromatin modifications and alternative splicing of neuronal genes linked to autism","volume":"30","author":"Shah","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111312_bib79","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/cercor\/bhy041","article-title":"Neural cell adhesion molecule 2 (NCAM2)-Induced c-src-dependent propagation of submembrane Ca2+ spikes along dendrites inhibits synapse maturation","volume":"29","author":"Sheng","year":"2018","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.celrep.2022.111312_bib80","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Res."},{"key":"10.1016\/j.celrep.2022.111312_bib81","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.aav5386","article-title":"Potassium channel dysfunction in human neuronal models of Angelman syndrome","volume":"366","author":"Sun","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111312_bib82","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ydbio.2020.09.012","article-title":"FMR1 loss in a human stem cell model reveals early changes to intrinsic membrane excitability","volume":"468","author":"Susco","year":"2020","journal-title":"Dev. Biol."},{"key":"10.1016\/j.celrep.2022.111312_bib83","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/febs.15214","article-title":"The re-emerging pathophysiological role of the cystathionine-beta-synthase - hydrogen sulfide system in Down syndrome","volume":"287","author":"Szabo","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.celrep.2022.111312_bib84","doi-asserted-by":"crossref","first-page":"a024539","DOI":"10.1101\/cshperspect.a024539","article-title":"Genetics of beta-amyloid precursor protein in alzheimer's disease","volume":"7","author":"Tcw","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.celrep.2022.111312_bib85","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm0196-93","article-title":"Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome","volume":"2","author":"Teller","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111312_bib86","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111312_bib87","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41593-018-0287-x","article-title":"Widespread RNA editing dysregulation in brains from autistic individuals","volume":"22","author":"Tran","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2022.111312_bib88","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-3-642-21649-7_16","article-title":"Fragile X syndrome: a psychiatric perspective","volume":"54","author":"Tranfaglia","year":"2012","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.celrep.2022.111312_bib89","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1073\/pnas.1814385116","article-title":"Phosphoregulated FMRP phase separation models activity-dependent translation through bidirectional control of mRNA granule formation","volume":"116","author":"Tsang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111312_bib90","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/ncomms5011","article-title":"De novo SOX11 mutations cause Coffin-Siris syndrome","volume":"5","author":"Tsurusaki","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111312_bib91","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13229-020-00350-5","article-title":"Elevated de novo protein synthesis in FMRP-deficient human neurons and its correction by metformin treatment","volume":"11","author":"Utami","year":"2020","journal-title":"Mol. Autism."},{"key":"10.1016\/j.celrep.2022.111312_bib92","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1073\/pnas.1216575110","article-title":"Deficits in human trisomy 21 iPSCs and neurons","volume":"110","author":"Weick","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111312_bib93","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/hmg\/ddx387","article-title":"Loss of Drosophila FMRP leads to alterations in energy metabolism and mitochondrial function","volume":"27","author":"Weisz","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2022.111312_bib94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fnmol.2016.00147","article-title":"APP causes hyperexcitability in fragile X mice","volume":"9","author":"Westmark","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.celrep.2022.111312_bib95","doi-asserted-by":"crossref","first-page":"e26549","DOI":"10.1371\/journal.pone.0026549","article-title":"Reversal of fragile X phenotypes by manipulation of AbetaPP\/Abeta levels in Fmr1KO mice","volume":"6","author":"Westmark","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111312_bib96","doi-asserted-by":"crossref","first-page":"e109749","DOI":"10.1371\/journal.pone.0109749","article-title":"Functional study of NIPA2 mutations identified from the patients with childhood absence epilepsy","volume":"9","author":"Xie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111312_bib97","doi-asserted-by":"crossref","first-page":"aaf2669","DOI":"10.1126\/science.aaf2669","article-title":"Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons","volume":"352","author":"Yi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2022.111312_bib98","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid single-step induction of functional neurons from human pluripotent stem cells","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111312_bib99","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuroscience.2017.02.044","article-title":"A novel role of fragile X mental retardation protein in pre-mRNA alternative splicing through RNA-binding protein 14","volume":"349","author":"Zhou","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.celrep.2022.111312_bib100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.aaw5185","article-title":"Activation of the ISR mediates the behavioral and neurophysiological abnormalities in Down syndrome","volume":"366","author":"Zhu","year":"2019","journal-title":"Science"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722011366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722011366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:03:03Z","timestamp":1775476983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722011366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2211124722011366"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111312","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular convergence between Down syndrome and fragile X syndrome identified using human pluripotent stem cell models","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"111312"}}